The HHS-declared public health emergency for COVID-19 ended on May 11, 2023 (NOT-OD-23-095). With this milestone, we are also closing out our series of blogs on the distributions of gender and race of designated principal investigators (PIs) of R01 and RPG applications submitted before and after the onset of the pandemic. This final post builds on previous … Continue reading “Final Career Stage Analyses of Applications Submitted During the Pandemic (Part 7)”
With the expiration of the Public Health Emergency on May 11 comes the end of the special exception that allowed applicants to submit a one-page update of preliminary data as post-submission materials. However, going forward, NIH is revising our standard post-submission material policy.
Ending After May 11, 2023: Common Rule Exceptions to the Use of a Single IRB for Multi-site Research
The extramural community is reminded that as of May 11, 2023, NIH will no longer be able to grant single IRB exceptions for multi-site research that is subject to the revised Common Rule, due to the expiration of the Federal Public Health Emergency for COVID-19.
Today we published our first NIH UNITE Progress Report! Covering Fiscal Years 2021–2022, the UNITE Progress Report describes NIH’s actions to identify and address structural racism that may exist within the NIH and in the biomedical and behavioral research enterprise.
We looked at applications broken down by career stage in June 2022. It was interesting to notice slowly increasing trends in the proportions of early stage investigator applications submitted by women and by underrepresented minorities. We repeat these career stage analyses here, specifically focusing on applications received between January 8 and September 7 in six consecutive years.
OLAW Not Accepting Requests for Semiannual Facility Inspection Waivers Due to COVID-19 as of October 1, 2022
Effective October 1, 2022, the NIH Office of Laboratory Animal Welfare (OLAW) will no longer accept requests for waivers to conduct the semiannual facility inspections due to COVID-19.
In earlier posts, we looked at the distributions of gender and race of designated principal investigators (PIs) of R01 and RPG applications submitted before and after the onset of the COVID-19 pandemic. Here we extend on our prior analyses by presenting R01-equivalent application data on PI characteristics of Early Stage Investigators (ESIs).
It’s worth reflecting that it has been more than two years since the COVID-19 pandemic began. Let’s look back to the months of early to mid-2020 when the nation (and the rest of the world) faced a “novel” coronavirus, one which we knew could be fatal and for which there was little knowledge about how it spreads and no known effective treatment, limited diagnostic tests, and no vaccine. How did NIH make fast and meaningful contributions to respond to the pandemic?
Guidance for Applicants Preparing Applications for Summer 2022 Due Dates During the COVID-19 Pandemic
For applicants preparing applications for the summer 2022 due dates, NIH recently extended the guidance that while grant applications should not include contingency or recovery plans for problems resulting from the COVID-19 pandemic, investigators may address effects due to the pandemic on productivity or other scoreable issues in the personal statement of the biosketch.
Reminder: NIH Will Continue to Accept Preliminary Data as Post-Submission Material Through January 2023 Councils
NIH will continue to accept a one-page update with preliminary data as post-submission materials for applications submitted for summer 2022 due dates, ONLY if the Funding Opportunity Announcement (FOA) used for submission allowed preliminary data in the application.